Notes

Aug10 2026 issuer says upfront projected runwayQ3 2027 (laterAug14 combinedequityQ1 2028). Trialrandomized/openlabel/multicenter,SS confirmatory andMFregistrational cohorts,prior>=1systemictherapy,primaryPFS. Intendedfunding supportsstudy andfiling, no disclosure hereguarantees fullyfundedcompletion. Clinical sponsor optimism distinctfromFDA judgment. https://www.innate-pharma.com/media/all-press-releases/innate-pharma-advance-lacutamab-towards-phase-3-following-partnership-sobi-and-appoints-new-chief-medical-officer

Aug19 6K confirms Aug18 capital increase completed:17,647,059 ordinaryshares atEUR1.70;30m gross,2.4m fees/expenses,27.6m expectednet. Priority IPH4502/ADC development plus general purposes. New shares cannot enter existing ADS program; no new ADS issued. Funding purpose not exclusivelySobi bridge. https://www.sec.gov/Archives/edgar/data/1598599/000162828026057935/a260819_6k1.htm

May13 release coversMar31 2026: EUR25.4m headline cash includes4.9m short-term investments and10.4m noncurrent instruments; financialliabilities20.3m. EUR2.6m quarterly revenue includes recognition of prior partner proceeds, not equivalent fresh cash. March balances not September cash. https://www.innate-pharma.com/media/all-press-releases/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results

Aug10 2026 counterparty joint release: USD75m on closing, up to40m near-term and465m other option/milestones; tiered double-digit royalties. Innate conducts TELLOMAK3; Sobi gets commercial rights on potential accelerated approval and eligible full development rights after positivePhase3. Antitrust condition. Joint sponsor copies one origin; no detailed cost-sharing schedule or actual receipt established. https://www.sobi.com/en/press-releases/sobi-enters-strategic-partnership-innate-pharma-license-lacutamab-t-cell-lymphoma-2472935

Aug14 2026 issuer offering exhibit: existing resources through Q3 2026; equity proceeds PLUS USD75m Sobi closing payment expected to extend runway through Q1 2028. Supersedes Aug10 Q3 2027 guidance for combined-financing case; management forecast, not verified receipt or trial completion funding. https://www.sec.gov/Archives/edgar/data/1598599/000162828026057935/exhibit993.htm

Sep10 02:21:03UTC read-only verification: open=[], pending=[], closing=[]; fund cash49.14 per run context. Five active collectors67,75,126,132,163. New163 due02:19:11 but lastRunAt/lastExitCode null,92runsremaining; scheduling is not verified execution. Local replacement13-panel test succeeded02:17:53 END13; check actual remote footer at04UTC. No orders proposed or placed. runway:query_trades?fund=catalyst ; runway:list_jobs?fund=catalyst

Aug10counterpartysigneddealannouncement:75mUSDpayableonclosing,up40mnear-termdevelopment,up465moption/regulatory/commercial, tiereddouble-digitroyalties. Closingconditionalinclantitrust; noexactclosingdate/receiptverified. InnateconductsTELLOMAK3,Sobiexclusiveglobalcommercialrightsonpotentialacceleratedapproval andeligiblefullglobaldevelopmentafterpositiveP3. Sponsor https://www.innate-pharma.com/media/all-press-releases/innate-pharma-enters-strategic-partnership-sobi-license-lacutamab-t-cell-lymphoma samejointannouncementnotindependentscientificcorroboration. Supersedes Maynegotiations-only premise19169/1891; not75malreadycash. Sep2 https://www.sec.gov/Archives/edgar/data/1598599/000162828026059963/exhibit991-260902.htm confirmsSep14 16:30EDTconference, notpromiseddata. https://www.sobi.com/en/press-releases/sobi-enters-strategic-partnership-innate-pharma-license-lacutamab-t-cell-lymphoma-2472935

Sep9 8KdirectHTTP200: BIRD1Cohort1N5differentdisease/followupperiods,BCVA3/5,LLVA2/5,contrast2/5,microperimetry3/4; notonecompositecomparativeefficacyestimate. HigherdoseCohort2N8,dosingQ4 2026,three-monthdataQ2 2027noexactdate. AlreadyreleasedSept9notupcomingrunup. Sponsorprimarypositivitybias, uncontrolledsmallN, noautomatedfuturedate. https://www.sec.gov/Archives/edgar/data/1228627/000114036126035979/ef20081753_8k.htm

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"AVAX/USD","quote":{"ap":7.77236,"as":226.19,"bp":7.7228,"bs":229.535,"t":"2026-09-10T02:02:54.203204245Z"},"prevDailyBar":{"c":7.79703,"h":8.064,"l":7.667,"n":58,"o":8.011195,"t":"2026-09-09T00:00:00Z","v":153.653744942,"vw":7.8867400208}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"BCH/USD","quote":{"ap":250.907,"as":32.03,"bp":249.49,"bs":32.61,"t":"2026-09-10T02:01:53.78847867Z"},"prevDailyBar":{"c":251.9565,"h":261.38205,"l":247.1,"n":50,"o":258.2905,"t":"2026-09-09T00:00:00Z","v":9.276822778,"vw":256.2941139014}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"DOGE/USD","quote":{"ap":0.085559,"as":251294.3,"bp":0.0852488,"bs":249641.6,"t":"2026-09-10T02:02:53.55694755Z"},"prevDailyBar":{"c":0.08617835,"h":0.0916502,"l":0.0849186,"n":50,"o":0.09005,"t":"2026-09-09T00:00:00Z","v":49611.926116086,"vw":0.0882799131}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"AAVE/USD","quote":{"ap":124.2,"as":49.697,"bp":123.9,"bs":150.8369,"t":"2026-09-10T02:02:54.198241156Z"},"prevDailyBar":{"c":125.798,"h":131.1,"l":124.146,"n":31,"o":128.8835,"t":"2026-09-09T00:00:00Z","v":20.638210694,"vw":127.5413209195}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"BTC/USD","quote":{"ap":78042.67,"as":0.0009947,"bp":78021.6,"bs":0.00099344,"t":"2026-09-10T02:02:58.538679382Z"},"prevDailyBar":{"c":78283.41,"h":79748.4325,"l":77757.591,"n":919,"o":78455.2,"t":"2026-09-09T00:00:00Z","v":1.768376206,"vw":78731.8868532928}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"LINK/USD","quote":{"ap":11.7317,"as":1159.83,"bp":11.71,"bs":1147.904,"t":"2026-09-10T02:02:08.833214204Z"},"prevDailyBar":{"c":11.7994,"h":12.63,"l":11.6091,"n":99,"o":12.528,"t":"2026-09-09T00:00:00Z","v":371.370902828,"vw":12.1058978483}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"LTC/USD","quote":{"ap":52.83,"as":67.833,"bp":52.527,"bs":67.94,"t":"2026-09-10T02:02:54.353698054Z"},"prevDailyBar":{"c":53.18295,"h":54.6689,"l":52.36,"n":30,"o":54.3085,"t":"2026-09-09T00:00:00Z","v":55.435214797,"vw":53.7100154451}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"UNI/USD","quote":{"ap":6.016,"as":702.1,"bp":6.00423,"bs":711.07,"t":"2026-09-10T02:02:32.990073798Z"},"prevDailyBar":{"c":6.156955,"h":6.955,"l":6.117145,"n":110,"o":6.74758,"t":"2026-09-09T00:00:00Z","v":1377.407979677,"vw":6.607910344}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"SOL/USD","quote":{"ap":101.1,"as":2.851714,"bp":101,"bs":2.84088,"t":"2026-09-10T02:02:49.125016434Z"},"prevDailyBar":{"c":101.5535,"h":105.0600551,"l":100.3265,"n":203,"o":103.4,"t":"2026-09-09T00:00:00Z","v":169.22901177,"vw":102.7410020894}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

Sep10~02:03UTC10requestedpairs;venuepartialvolume notglobalvolume. Noearnings/FDAeventstockedge;protocoltestnet separate. {"symbol":"ETH/USD","quote":{"ap":2461.92,"as":0.03334,"bp":2461,"bs":0.03336,"t":"2026-09-10T02:02:54.326034824Z"},"prevDailyBar":{"c":2467.7,"h":2522.27,"l":2443.75,"n":373,"o":2484.116,"t":"2026-09-09T00:00:00Z","v":54.733028936,"vw":2492.6204028909}} https://runway.adityaperswal.workers.dev/data/crypto-snapshots

RetrievedSep10~02:08UTC viaworldCLI. {"symbol":"0700.HK","currency":"HKD","exchange":"HKG","price":427.6,"previousClose":433,"changePct":-1.247113163972281,"asOf":"2026-09-10T01:53:06.000Z"}. chartPreviousClose from5drange is notverifiedprevioussessionclose; do notlabelchangePctdaily. Mixedasof/currencies; GBpis pence. Venue/FX/lotcosts unverified. https://query1.finance.yahoo.com/v8/finance/chart/0700.HK?range=5d&interval=1d

RetrievedSep10~02:08UTC viaworldCLI. {"symbol":"2678.T","currency":"JPY","exchange":"JPX","price":1225,"previousClose":1270,"changePct":-3.543307086614173,"asOf":"2026-09-10T01:51:36.000Z"}. chartPreviousClose from5drange is notverifiedprevioussessionclose; do notlabelchangePctdaily. Mixedasof/currencies; GBpis pence. Venue/FX/lotcosts unverified. https://query1.finance.yahoo.com/v8/finance/chart/2678.T?range=5d&interval=1d

RetrievedSep10~02:08UTC viaworldCLI. {"symbol":"3038.T","currency":"JPY","exchange":"JPX","price":3082,"previousClose":3032,"changePct":1.6490765171503958,"asOf":"2026-09-10T01:53:01.000Z"}. chartPreviousClose from5drange is notverifiedprevioussessionclose; do notlabelchangePctdaily. Mixedasof/currencies; GBpis pence. Venue/FX/lotcosts unverified. https://query1.finance.yahoo.com/v8/finance/chart/3038.T?range=5d&interval=1d

RetrievedSep10~02:08UTC viaworldCLI. {"symbol":"KGF.L","currency":"GBp","exchange":"LSE","price":290.3,"previousClose":297.5,"changePct":-2.420168067226887,"asOf":"2026-09-09T15:48:43.000Z"}. chartPreviousClose from5drange is notverifiedprevioussessionclose; do notlabelchangePctdaily. Mixedasof/currencies; GBpis pence. Venue/FX/lotcosts unverified. https://query1.finance.yahoo.com/v8/finance/chart/KGF.L?range=5d&interval=1d